CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Glenmark gets CDSCO panel nod to market Remogliflozin, Teneligliptin, Metformin FDC drug Medical Dialogues Team17 Nov 2021 4:59 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial and bioequivalence study waver, the Subject Expert Committee (SEC) of the Central...
Cadila gets CDSCO panel nod to manufacture, market Calcium Polystyrene Sulphonate suspension Medical Dialogues Team16 Nov 2021 6:57 PM ISTNew Delhi: Pharmaceutical major Cadila Healthcare has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs...
IPC releases list of new impurities, Indian Pharmacopoeial Reference standards, Details Medical Dialogues Team15 Nov 2021 5:41 PM ISTNew Delhi: Through recently issued notice the Indian Pharmacopoeia Commission (IPC) has added 7 new Indian Pharmacopoeial Reference standards and 23...
36 drug samples fail to qualify CDSCO test Farhat Nasim14 Nov 2021 5:25 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 36...
Johnson and Johnson to split into 2 companies Medical Dialogues Team13 Nov 2021 5:01 PM ISTNew Delhi: US pharma giant Johnson and Johnson (JnJ) has recently announced that it is splitting into two companies, separating the division that...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Pharma firms seek Govt nod to hike drug prices by 20 percent: Report Medical Dialogues Team11 Nov 2021 4:50 PM ISTNew Delhi: In view of the unprecedented crisis faced by Indian pharmaceutical firms due to the tremendous escalation of input costs, a lobby group...
CDSCO raises cybersecurity alert on Medtronic remote controllers used in insulin pumps Medical Dialogues Team10 Nov 2021 2:07 PM ISTNew Delhi: Citing potential cybersecurity risks, the Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for...
CDSCO extends date of getting license for medical devices to June 30, 2022, Details Medical Dialogues Team9 Nov 2021 6:00 PM ISTNew Delhi: In relief to manufacturers and importers of medical devices, the Central Drug Standard Control Organisation (CDSCO) has extended the date...
Firm that managed Pfizer COVID vaccine trial sites falsified data, claims BMJ Medical Dialogues Team8 Nov 2021 6:27 PM ISTNew Delhi: In a shocking revelation, a whistleblower has accused Ventavia, a Pfizer Covid-19 vaccine phase 3 clinical trial subcontractor, of...
